Ligand-activated EGFR/MAPK Signaling but Not PI3K, Are Key Resistance Mechanisms to EGFR-therapy in Colorectal Cancer
Nature communications(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined